188 related articles for article (PubMed ID: 16288922)
1. New insights into the catalytic activation of the MAPK phosphatase PAC-1 induced by its substrate MAPK ERK2 binding.
Zhang Q; Muller M; Chen CH; Zeng L; Farooq A; Zhou MM
J Mol Biol; 2005 Dec; 354(4):777-88. PubMed ID: 16288922
[TBL] [Abstract][Full Text] [Related]
2. The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP.
Pettiford SM; Herbst R
Oncogene; 2000 Feb; 19(7):858-69. PubMed ID: 10702794
[TBL] [Abstract][Full Text] [Related]
3. Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1.
Slack DN; Seternes OM; Gabrielsen M; Keyse SM
J Biol Chem; 2001 May; 276(19):16491-500. PubMed ID: 11278799
[TBL] [Abstract][Full Text] [Related]
4. Structure of the gene encoding the murine dual specificity tyrosine-threonine phosphatase PAC1.
Gerondakis S; Economou C; Grumont RJ
Genomics; 1994 Nov; 24(1):182-4. PubMed ID: 7896276
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase.
Saxena M; Williams S; Taskén K; Mustelin T
Nat Cell Biol; 1999 Sep; 1(5):305-11. PubMed ID: 10559944
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of PTP-SL/PTPBR7 catalytic domain: implications for MAP kinase regulation.
Szedlacsek SE; Aricescu AR; Fulga TA; Renault L; Scheidig AJ
J Mol Biol; 2001 Aug; 311(3):557-68. PubMed ID: 11493009
[TBL] [Abstract][Full Text] [Related]
7. The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma.
Givant-Horwitz V; Davidson B; Goderstad JM; Nesland JM; Tropé CG; Reich R
Gynecol Oncol; 2004 May; 93(2):517-23. PubMed ID: 15099972
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the inducible nuclear dual-specificity phosphatase DUSP5 by ERK MAPK.
Kucharska A; Rushworth LK; Staples C; Morrice NA; Keyse SM
Cell Signal; 2009 Dec; 21(12):1794-805. PubMed ID: 19666109
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the MAPK phosphatase Pyst1 catalytic domain and implications for regulated activation.
Stewart AE; Dowd S; Keyse SM; McDonald NQ
Nat Struct Biol; 1999 Feb; 6(2):174-81. PubMed ID: 10048930
[TBL] [Abstract][Full Text] [Related]
10. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases.
Owens DM; Keyse SM
Oncogene; 2007 May; 26(22):3203-13. PubMed ID: 17496916
[TBL] [Abstract][Full Text] [Related]
12. Structure of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: structure of a KIM phosphatase with phosphate bound at the active site.
Mustelin T; Tautz L; Page R
J Mol Biol; 2005 Nov; 354(1):150-63. PubMed ID: 16226275
[TBL] [Abstract][Full Text] [Related]
13. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
Easton JB; Royer AR; Middlemas DS
J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
[TBL] [Abstract][Full Text] [Related]
14. Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents.
Muñoz JJ; Tárrega C; Blanco-Aparicio C; Pulido R
Biochem J; 2003 May; 372(Pt 1):193-201. PubMed ID: 12583813
[TBL] [Abstract][Full Text] [Related]
15. PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression.
Yin Y; Liu YX; Jin YJ; Hall EJ; Barrett JC
Nature; 2003 Apr; 422(6931):527-31. PubMed ID: 12673251
[TBL] [Abstract][Full Text] [Related]
16. Discordance between the binding affinity of mitogen-activated protein kinase subfamily members for MAP kinase phosphatase-2 and their ability to activate the phosphatase catalytically.
Chen P; Hutter D; Yang X; Gorospe M; Davis RJ; Liu Y
J Biol Chem; 2001 Aug; 276(31):29440-9. PubMed ID: 11387337
[TBL] [Abstract][Full Text] [Related]
17. Docking interactions induce exposure of activation loop in the MAP kinase ERK2.
Zhou T; Sun L; Humphreys J; Goldsmith EJ
Structure; 2006 Jun; 14(6):1011-9. PubMed ID: 16765894
[TBL] [Abstract][Full Text] [Related]
18. Functional assignment of MAPK phosphatase domains.
Nordle AK; Rios P; Gaulton A; Pulido R; Attwood TK; Tabernero L
Proteins; 2007 Oct; 69(1):19-31. PubMed ID: 17596826
[TBL] [Abstract][Full Text] [Related]
19. Spatially separate docking sites on ERK2 regulate distinct signaling events in vivo.
Dimitri CA; Dowdle W; MacKeigan JP; Blenis J; Murphy LO
Curr Biol; 2005 Jul; 15(14):1319-24. PubMed ID: 16051177
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase Cdelta-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death.
Choi BH; Hur EM; Lee JH; Jun DJ; Kim KT
J Cell Sci; 2006 Apr; 119(Pt 7):1329-40. PubMed ID: 16537649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
